Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
In the lab, St. Jude scientists identify possible COVID-19 treatment
Immunologists have determined the process driving life-threatening inflammation, lung damage and organ failure in patients with COVID-19, sepsis and other inflammatory disorders suggesting possible treatment using existing drugs.
-
Sara Federico, M.D., receives NCI award for her leadership in developing clinical trials for pediatric cancer
Sara Federico, MD, received the NCI award for substantial impact in the field of childhood solid tumors through the development and conduct of clinical trials.
-
St. Jude researchers are among the most highly cited scientists in the last decade
Scientists at St. Jude Children’s Research Hospital are included on the Highly Cited Researchers 2020 list, which features some of the world’s most influential researchers.
-
Metabolic signaling plays a crucial role in regulating specialized T cells
Scientists at St. Jude Children’s Research Hospital have identified how metabolic signaling pathways influence key immune cells with implications for treating autoimmune disorders and cancer.
-
Cytokine storms play a limited role in moderate-to-severe COVID-19
St. Jude Children’s Research Hospital and Washington University research suggests steroids such as dexamethasone should be reserved for the sickest COVID-19 patients.
-
St. Jude and the University of Tennessee Health Science Center begin recruiting adult participants for phase 3 COVID-19 vaccine clinical trial
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center will offer a testing site for a phase 3 COVID-19 vaccine clinical research study.